Company profile: DNA Genotek
1.1 - Company Overview
Company description
- Provider of biological sample collection, stabilization, and preparation products for health research institutes, offering human and animal DNA/RNA collection kits, stabilization and preparation reagents, and self-collection devices for saliva, oral microbiome, and first-void urine (OMNIgene, ORAcollect, Colli-Pee), plus prepIT kits and reagents for DNA extraction and inhibitor removal for downstream assays.
Products and services
- ORAcollectâ—RNA: An IVD-compliant system that collects, stabilizes, and transports high-quality RNA from saliva for in vitro diagnostic use, with integrated collection and preservation
- OMNIgeneâ—SALIVA DNA and RNA: A multi-omic kit that collects, stabilizes, and prepares DNA and RNA from saliva samples for health research institutes
- Colli-Pee: A first-void urine self-collection device for non-invasive sampling suitable for infectious disease testing, biomarker discovery, and diagnostic detection
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to DNA Genotek
Bruker
HQ: United States
Website
- Description: Provider of analytical and medical instruments covering NMR, ESR, FT-IR and X-ray spectroscopy. MALDI Imaging to visualize molecular distribution in tissue sections; neofleX MALDI-TOF/TOF benchtop MS for protein and peptide analysis; Q6 NEWTON optical emission spectrometer for precise metal and alloy composition; BEAM FT-NIR for real-time process control of solid and semi-solid materials; and Dektak Pro profilometer for semiconductor surfaces.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bruker company profile →
Kendall Research Systems
HQ: United States
Website
- Description: Provider of pioneering novel tools for neuroscience discovery using optogenetic techniques, operating as an R&D think tank developing technologies in bioinstrumentation, ultra-low power computation, and communications links; originated in 2011 as an optical neural interface technology spin-out from MIT's Synthetic Neurobiology Lab.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kendall Research Systems company profile →
Labcyte
HQ: United States
Website
- Description: Provider of Echo Acoustic Liquid Handling systems and laboratory instrumentation for life sciences applications, using focused acoustic energy to eject nanoliter-scale droplets from one plate to another with high accuracy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Labcyte company profile →
ViaCord
HQ: United States
Website
- Description: Provider of women's health biotechnology services, including ViaCord for preserving newborn umbilical cord blood, cord tissue banking, and ViaCyte for cryopreservation of unfertilized eggs, plus newborn genomic offerings such as DNA preservation, celiac and lactose risk testing, a panel analyzing over 270 genes, and whole genome sequencing of 22,000 genes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ViaCord company profile →
Molecular Devices
HQ: United States
Website
- Description: Provider of analytical solutions for cell and protein biology, enabling customers to unravel complex biological systems. Offerings include AI-driven automated cell culture (CellXpress.ai), high-content confocal imaging (ImageXpress), SpectraMax microplate readers, SoftMax Pro software for data analysis, GxP compliance solutions, and an Organoid Innovation Center for 3D biological models.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Molecular Devices company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for DNA Genotek
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to DNA Genotek
2.2 - Growth funds investing in similar companies to DNA Genotek
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for DNA Genotek
4.2 - Public trading comparable groups for DNA Genotek
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →